| Date | Title | Description |
| 13.09.2023 | - | The German Private Equity Investor SHS Capital has completed the Final Closing of its sixth fund generation The targeted fund volume of EUR 200 million could significantly be overachieved with ca. EUR 270 million and is more than doubling t... |
| 10.08.2023 | - | SHS Capital has acquired a majority stake in the Baden-Württemberg-based robotics company ESSERT GmbH ESSERT develops intelligent automation solutions for a wide range of applications with a focus on the pharmaceutical, life science and gen... |
| 07.07.2023 | - | CAM Bioceramics B.V., based in Leiden, the Netherlands, is a leading global manufacturer of innovative calcium phosphate solutions for Medtech and LifeScience applications Together with ING Corporate Investments and several Co-Investors, th... |
| 27.06.2023 | - | Spiegelberg GmbH & Co. KG is one of the leading suppliers in the field of manufacturing devices and consumables for intracranial pressure measurement and has been able to grow strongly in recent years Luciole Medical AG, which specialis... |
| 22.06.2023 | - | SHS partners with the founders of MESI, a fast-growing Slovenia-based diagnostic company growing revenues >50% p.a. in the last 5 years MESI’s cutting-edge technology digitalizes medical assessment, resulting in workflow optimisation, co... |
| 02.03.2023 | - | SHS invests €10 million euro from its newly launched sixth fund generation into the Zurich-based growth company Simulands AG develops, produces, and distributes innovative simulation devices and tools for cardiovascular interventions The in... |
| 20.12.2022 | - | Medical technology market in Germany with slight growth in 2021 Pandemic leaves positive as well as negative traces on medical technology companies in second year, with the former predominating SHS expects a good development for medical tec... |
| 14.12.2022 | - | On the initiative of Elisa Mayer and Tomma Hinke, two football clubs, SSC Tübingen and SV Bühl, have launched an inclusive training format. This means that children and young people with disabilities who are interested in football now have ... |
| 21.11.2022 | - | The European Medical Device Regulation (MDR), whose goals were initially supported by the European medtech industry, has been in force since May 2022. After half a year, the situation for the medium-sized medtech industry is devastating. |
| 28.10.2022 | - | Blazejewski MEDI-TECH GmbH is one of the technology leaders in the field of complex 2D and 3D endoscopy and has been able to grow very strongly in recent years Reinhold Blazejewski, Founder and Managing Director of Blazejewski MEDI-TECH, al... |
| 30.09.2022 | - | At the beginning of the Corona pandemic, many market participants were looking for investment opportunities in the health market. Companies like BioNTech, which had previously remained niche, became stock market stars. Can investors also pr... |
| 13.09.2022 | - | Medium-sized medical technology companies are facing many challenges in these geopolitically turbulent times: Supply chain problems, the MDR medical device regulation, digitalisation, energy shortages and rising refinancing costs due to the... |
| 18.08.2022 | - | Tübingen / 18.08.2022 Manfred Ulmer-Weber has been appointed to the management board of SHS Gesellschaft für Beteiligungsmanagement mbH. Ulmer-Weber will be jointly responsible for the allocation of the new SHS VI fund of the Tübingen-based... |
| 18.07.2022 | - | SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over 220 million euros for its sixth fund at the first closing. Faster than expected, the Tübingen-based healthcare investor has already exceeded its target of ... |
| 16.05.2022 | - | Digital health applications (DiGA) can improve medical care. |
| 09.05.2022 | - | Before joining SHS, Lukas worked as a manager at one of the Big Four auditing firms in southern Germany. He completed his Bachelor of Science in Business Administration with a focus on Corporate Accounting and Finance at the LMU in Munich. ... |
| 22.04.2022 | - | The fast-growing Norwegian healthcare provider Dropin enables short-term medical consultation and treatment – in person on site as well as digitally via app Dropin posted revenue of more than 30m EUR in 2021, constituting a CAGR of more tha... |
| 21.04.2022 | - | The fast-growing MedTech company phenox specialises in instruments and implants for the neurointerventional therapy of stroke With the growth capital provided by SHS et al., the Bochum-based company has developed from a start-up into a glob... |
| 14.04.2022 | - | With the Corona pandemic, the healthcare sector, among others, has become the focus of increased attention among investors. SHS in Tübingen, an investment company specialising in the healthcare sector, outlines the asset classes that can be... |
| 06.04.2022 | - | The healthcare sector has come under increased public scrutiny as a result of the Corona pandemic. M&A deals in the sector have reached a high level in 2021. Many lighthouse companies, however, choose the US market for the participation... |
| 09.03.2022 | - | Since 1993, the Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH has successfully developed and sold more than 68 companies from the medtech industry with capital and know-how. Read three success stories from our contribution ... |
| 21.02.2022 | - | Consistent and reliable: the healthcare sector has been the innovation engine of the German and international economy for years |
| 15.02.2022 | - | c-LEcta was able to translate technology leadership into tremendous commercial growth during the holding period of SHS Leipzig-based c-LEcta’s clients include international corporations in the pharmaceutical, chemical and food industries. W... |
| 03.02.2022 | - | VAMDRUP, Denmark, February 3rd, 2022 – Impilo and SHS have acquired Lowenco A/S (“Lowenco” or the “Company”) from its founder and owners. Lowenco was founded 2013 in Vamdrup, Denmark, and develops, manufactures, markets, and installs large ... |
| 22.12.2021 | - | As an important future and economic factor, the healthcare industry has become more visible to the public in the past 20 months. There has also been significant movement in the market for healthcare investments. In the first half of 2021, t... |
| 21.12.2021 | - | Medical technology market in Germany to remain at a high level in 2020, but with slight declines Pandemic leaves both positive and negative traces on medical technology companies SHS expects better development for medical technology than fo... |
| 16.12.2021 | - | The renowned Hertie-Institut Tübingen together with the Neurological Clinic of the Universitätsklinikum Tübingen form the “Centre for Neurology”. The centre was created with the contract signed in 2001 between the Gemeinnützige Hertie-Stift... |
| 08.12.2021 | - | In the car industry in particular, a robot-controlled production process already seems normal to us. But in medicine? Let’s take a look into the operating theatre of a urological centre in Germany in 2021! |
| 12.11.2021 | - | Large investors often expect double-digit returns from private equity investments. Would this also be achievable for private investors? Risks and peculiarities should be very well known. |
| 09.11.2021 | - | This funding round allocated in tranches will strengthen PathoQuest’s position as a leading NGS-based biosafety CRO for the biopharmaceutical industry. Paris, FRANCE, Tübingen, GERMANY – November 9th, 2021 – PathoQuest, a pioneer in the qua... |
| 05.11.2021 | - | Advances in technology are enabling increasingly precise and individualised treatment of diseases. |
| 11.10.2021 | - | The systemic use of health data enables the transformation from hypothesis-driven medicine to data-based medicine. |
| 22.09.2021 | - | SHS has been investing according to ethical standards for more than 25 years and its ESG policy is an important aspect of investment decisions. Now it is also becoming a member of the PRI (UN Principles for Responsible Investment) The Tübin... |
| 13.09.2021 | - | Medical wearables and apps will be an essential part of telemedicine in the future. This offers new opportunities for established healthcare companies. |
| 12.08.2021 | - | The use of IT and AI increases efficiency and quality of care in medicine – but also the vulnerability of the systems. How do we combine progress with security? |
| 28.07.2021 | - | Atlas Antibodies acquires evitria Atlas Antibodies has agreed to acquire evitria, a world leader in transient recombinant antibody expression in CHO cells. This transformative acquisition brings together a leading provider of highly validat... |
| 28.07.2021 | - | Afinum and SHS Capital have sold their stakes in Switzerland-based diagnostic and therapeutic antibodies specialist Evitria toSweden-based Atlas Antibodies in a deal that values Evitria atmore than EUR 200m. |
| 22.07.2021 | - | An interview with Dr Hanno Kühn, Chief Investment Officer (CIO) and head of apoBank’s institutional investment business, and Hubertus Leonhardt, Managing Director and partner of SHS Gesellschaft für Beteiligungsmanagement mbH. Düsseldorf an... |
| 01.07.2021 | - | Artificial intelligence will revolutionise the healthcare sector in this decade. With smart concepts and innovative healthtech products, we can make the healthcare system more efficient and effective. |
| 22.06.2021 | - | The Tübingen-based healthcare investor SHS has accompanied Crystal GmbH on its growth path with its know-how, the required capital and extensive networks. Crystal’s optical components are used, for example, in the medical technology industr... |
| 04.06.2021 | - | For the future performance and efficiency in medical care, the degree of digitalisation will be decisive, in addition to the qualified specialist staff. |
| 27.05.2021 | - | Incision is rapidly expanding its platform for surgical performance and online training The German SHS Gesellschaft für Beteiligungsmanagement mbH and investor Rubio Impact Ventures from Amsterdam provide 5 million euros for the expansion o... |
| 06.05.2021 | - | Corona hits everyone, including the healthcare industry – which is essential to a functioning healthcare system. |
| 03.05.2021 | - | ntv reported in an exciting TV report about Mental Health Apps with focus on the DiGa of the SHS portfolio company Selfapy GmbH. It shows that digital therapies are increasingly arriving in mainstream care. Especially in the pandemic, low-t... |
| 22.04.2021 | - | In the course of a successful succession arrangement, Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH sells its shares in medigroba GmbH to Löwenstein Group With SHS as majority shareholder, medigroba has more than doubled re... |
| 22.04.2021 | - | Unquote reports on the sale of homecare specialist Medigroba to the Löwenstein Group. The deal is SHS’s second exit of 2021; the GP sold its stake in Crystal LaserSystems to Silver Investment Partners in March 2021. SHS expects to launch fu... |
| 01.04.2021 | - | ESG, SRI, impact investing: when did this start, and what is its importance in the healthcare sector? |
| 15.03.2021 | - | AMW GmbH announced today that Dr. Konstantin Petropoulos has been appointed Chief Executive Officer (CEO) effective March 15, 2021 This expands Dr. Friedrich Tegel and Philipp Karbach to the existing management team. |
| 15.03.2021 | - | The industry magazine “Plattform Life Sciences” asked investors and financing advisors about the mood after the Corona year 2020 and, among others, asked SHS partner Manfred Ulmer-Weber about current financing trends and how life science in... |
| 11.03.2021 | - | Tübingen-based healthcare investor SHS has provided capital and expertise to Crystal Laser Systems GmbH (CryLaS) on its way to becoming a leading, profitable provider of laser technology and is handing over the baton to Silver Investment Pa... |
| 11.03.2021 | - | In a Podcast Caroline Sai of EIT Health and our Partner Andre Zimmermann are discussing in which ways the new MDR is heavily affecting the whole European Medtech area – from start-ups to established medium-sized companies. In addition, SHS ... |
| 04.03.2021 | - | Digitization is one of the major challenges facing the medtech industry. Those who want to master them need courage, know-how and capital. |
| 04.02.2021 | - | ‘Brexit is done’, as British Prime Minister Johnson wholeheartedly announced. But what does this mean for the SME-based healthcare and medtech sector? Read about it the current column by Dr. André Zimmermann. |
| 14.01.2021 | - | SHS Gesellschaft für Beteiligungsmanagement mbH (SHS) has sold its shares in the Austrian life science supplier Single Use Support GmbH (SUS) to Pall Corporation. SUS sets new standards for the transport of liquid substances in the medtech ... |
| 12.01.2021 | - | The Tübingen-based medtech investor SHS is investing in Blue Ocean Spine GmbH, a developer for 3D-printed spinal implants Blue Ocean Spine is developing a portfolio of new spinal implants that can be precisely adapted to patient needs in si... |
| 07.01.2021 | - | With a population of around 1.4 billion, the People’s Republic of China is an enormously attractive market for medtech and life-science products. For foreign firms, this presents not only great opportunities but risks as well. By: Dr André ... |
| 29.12.2020 | - | ZDF TV reports in its heute Sendung (from min. 07:32) at prime time about our portfolio company GNA Biosolutions GmbH. The company has received emergency approval for its point-of-care test, which enables detection for COVID19 within 40 min... |
| 29.12.2020 | - | German molecular diagnostics startup GNA Biosolutions has received Emergency Use Authorization (Sonderzulassung) from the German Federal Institute for Drugs and Medical Devices (BfArM) for the GNA Octea SARS-CoV-2 Test System. The new techn... |
| 19.12.2020 | - | The Tübingen-based SHS Gesellschaft für Beteiligungsmanagement mbH invests from its SHS V fund in the Swiss-German specialty pharmaceuticals company Develco Pharma. |
| 18.12.2020 | - | Every year, counterfeit medicines cause harm to many patients, particularly in developing countries. This problem is being tackled by a joint project of the Tübingen-based Difäm and the Ecumenical Pharmaceutical Network (EPN) that aims to d... |
| 17.12.2020 | - | Tübingen-based industry investor SHS acquires minority share in formulation specialist Develco Pharma Develco specializes in the development, approval and production of innovative and generic specialty drugs and offers a unique and broad se... |
| 17.12.2020 | - | Positive economic news is rare in times of crisis. This makes this news from Graz all the more pleasing: an order worth millions of euros gives SHS portfolio company Tyromotion a positive outlook for the future. |
| 03.12.2020 | - | While the EU is significantly raising approval hurdles with the MDR, the US is putting medtech innovations in the fast lane with the Breakthrough Devices Program By: Dr André Zimmermann, partner at Tübingen-based industry investor SHS. He h... |
| 02.12.2020 | - | Unquote reports on the sale of our portfolio company puracon to the precision machining business Klingel medical metal, which is a portfolio company of IK Investment Partners. |
| 02.12.2020 | - | SHS Gesellschaft für Beteiligungsmanagement mbH, based in Tübingen, is selling its shares in puracon GmbH to Klingel medical metal GmbH, a portfolio company of IK Investment Partners. With 600 employees, Klingel Group is one of the leading ... |
| 20.11.2020 | - | The trade magazine of going public portrays SHS (page 50-51) as one of the oldest players in the financing of German life sciences companies, start-ups and SMEs, with a focus on medical technology, diagnostics, suppliers and digital health. |
| 05.11.2020 | - | Coronavirus, digitalisation, MDR, Brexit – companies in the medical technology sector face major, capital-intensive challenges. What is key at this stage? By: Dr André Zimmermann, partner at Tübingen-based industry investor SHS. He has deve... |
| 14.10.2020 | - | Effective October 1, 2020, Tübingen-based medtech investor SHS has appointed Prof. Marc O. Schurr, founder and Executive Board member of Ovesco AG, as Senior Advisor Schurr, a successful medtech entrepreneur and professor of experimental me... |
| 22.09.2020 | - | Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine Series A led by new investors Panakès Partners, INKEF Capital and SHS Gesellschaft für Beteiligungsmanagement Eindhoven, the ... |
| 02.09.2020 | - | Our portfolio company Miracor raised 24m EUR to fund three clinical trials, totaling 750 patients, and start commercialization of its PiCSO therapy. The PiCSO therapy reduces infarct sizes and therefore mortality and hospitalization of pati... |
| 11.08.2020 | - | The FAZ published a background article on the active M&A environment in medtech despite (and partially even supported by) the market conditions with a specific focus on the Siemens Healthineers / Varian Medical Systems transaction. Hube... |
| 05.08.2020 | - | How has the medical technology industry developed in comparison to the overall economy in recent years? The Schwäbische Zeitung (https://www.schwaebische.de) reports on the SHS Medical Technology Index. |
| 03.08.2020 | - | SHS sees medical technology back on track for success in Germany in 2019 Medical technology sector increases turnover by 10% in 2019 In spite of COVID-19, SHS expects the medical technology industry to outperform the German economy as a who... |
| 26.06.2020 | - | A real improvement in kidney transplant rejection diagnostics: The transplantation of a organ (e.g. kidney) is a highly invasive procedure, a high risk but also chance for the patient and a huge burden for the body to process. Furthermore, ... |
| 24.06.2020 | - | At MedtecLIVE, which will take place virtually for the first time on 1 July, everything will revolve around the topic of financing in medical technology, with the aim of networking the players in the medical technology sector. The programme... |
| 23.06.2020 | - | Heinz Jacqui (59) has been appointed Senior Advisor at SHS Gesellschaft für Beteiligungsmanagement effective June 1, 2020. By way of succession arrangements or growth financing, SHS specializes in investing in innovative healthcare companie... |
| 23.06.2020 | - | Miracor Medical SA (Miracor Medical) has announced the award of the CE Mark for its latest generation of PiCSO Impulse Catheter and PiCSO Impulse Console, which is indicated for the treatment of anterior STEMI patients. The new system featu... |
| 22.06.2020 | - | FAZ reports on the SHS portfolio company Selfapy, which offers online therapies for depression, anxiety and eating disorders. This enables patients who need acute help to bridge long waiting times until a doctor’s appointment. |
| 22.06.2020 | - | CE marking is expected for 2020 Submission at the FDA is expected for early 2021 On June 19, 2020, the Swiss Medtech company Advanced Osteotomy Tools (AOT) successfully completed the last surgery required for the first-in-man clinical study... |
| 27.05.2020 | - | The M&A consultancy Clairfield and Luther Rechtsanwaltsgesellschaft prepared this informative study with the support of the German Medical Technology Association (BVMed) and the German Engineering Federation (VDMA). The study gives you ... |
| 05.05.2020 | - | Dr. André Zimmermann, partner at SHS, was a guest in the BVK expert talk. Deputy Managing Director Swantje von Massenbach spoke to him about investments in the health sector, such as medical technology or diagnostics. Among other things, th... |
| 02.05.2020 | - | With the Investor Network Tyrol, the Tyrolean location agency brings companies and start-ups together with the right investors. In a discussion between Klaus Grössinger from the Investor Network of the Tyrolean location agency and Friedrich... |
| 22.04.2020 | - | “The high demand for digital health offers should not hide the fact that the industry is facing enormous risks,” says Cornelius Maas, SHS Senior Investment Manager, in a guest article in Handelsblatt. |
| 21.04.2020 | - | On April 1, 2020, Sascha Alilovic (46) was appointed Managing Partner of SHS Gesellschaft für Beteiligungsmanagement. Whether by way of succession arrangements or growth financing, SHS specializes in investing in innovative healthcare compa... |
| 14.04.2020 | - | Neuro Event Labs Oy closes EUR 3.9m Series A investment round from Hadean Ventures, SHS Gesellschaft für Beteiligungsmanagement and Maki.vc Proceeds to support commercial expansion in Europe as well as US market entry Investment round led b... |
| 09.04.2020 | - | While for most companies in Tyrol the corona crisis means the passing of an economic acid test, the Kufstein-based start-up company Single Use Support achieved a significant increase in sales in the first quarter of 2020. The technologies o... |
| 31.03.2020 | - | medigroba GmbH, with its headquarters in Balingen, continues to expand and has now also gained a foothold in Hesse following the expansion of the site in North Rhine-Westphalia, where people in need of care have been provided with medical a... |
| 12.03.2020 | - | Amidst the spread of the novel coronavirus COVID-19, the biopharmaceutical industry worldwide is researching for vaccines against the virus. The Tyrolean start-up Single Use Support GmbH is also involved: a biotech company from the USA reli... |
| 11.03.2020 | - | Der Kufsteiner Biopharma-Zulieferer Single Use Support ist in der Biopharma Branche heiß begehrt. Mit ihren innovativen Produkten zum Abfüllen sowie Einfrieren und Auftauen von Arzneimittelsubstanzen zogen die Firmengründer Johannes Kirchma... |
| 10.03.2020 | - | c-LEcta, a leading innovator and supplier of biotechnological products for regulated markets like food and pharma, is entering into a development partnership with the MDax-listed company Symrise. Founded in 2003, Symrise AG is one of the wo... |
| 09.03.2020 | c-LEcta: 5 questions to Tjebbe van der Meer, Head of Product Management | - |
| 09.03.2020 | - | - |
| 27.02.2020 | - | Blazejewski MEDI-TECH GmbH is a leading manufacturer of medical endoscopes SHS is acquiring a 24.9-percent stake in the company Blazejewski intends to advance sales and internationalization with the aid of SHS SHS Gesellschaft fuer Beteilig... |
| 03.02.2020 | - | Unquote reported on SHS backing mental health therapy provider Selfapy in their recent financing round. Selfapy raised the money to conduct further clinical studies and to continue to expand nationally and internationally. Selfapy is SHS fi... |
| 31.01.2020 | - | The medtech zwo magazine reported on the participation of SHS Tübingen in the endoscopy manufacturer Blazejewski MEDI-Tech GmbH from Sexau. The company develops and produces endoscopes and endoscopy cameras. Within the scope of a partnershi... |
| 31.01.2020 | - | Selfapy is Germany’s leading provider of online therapy for mental stress and is already cooperating with 16 health insurance funds SHS is expecting strong impulses for digital health companies from Germany’s new Digital Healthcare Act (DVG... |
| 30.01.2020 | - | In January, the Handelsblatt reported on the current financing round of Selfapy, a psychotherapy start-up that wants to make better and faster psychotherapy treatment possible with its app. Selfapy offers online courses for the treatment of... |
| 09.01.2020 | - | Single Use Support has been announced winner in the export category of the Young Entrepreneurs Award presented by Austrian business magazine “Gewinn”. Furthermore, the start-up was ranked fifth of 100 in the overall ranking. |
| 30.12.2019 | - | In an interview with Hubertus Leonhardt, managing director and partner of SHS, and Manfred Ulmer-Weber, investment manager and partner at SHS, VC Magazin reports on the development of the company and its current fifth fund (SHS V). SHS Tübi... |
| 01.12.2019 | - | “Swimming for All Children” is organized on a voluntary basis and was established in April 2015 in cooperation with Runder Tisch Kinderarmut (Round Table on Child Poverty) and Bündnis für Familie (Alliance for the Family) in Tübingen. A sur... |
